Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?

Lung cancer is still the leading cause of death among all cancers. During the last 15 years, pharmacogenomics of lung cancer have established targeted therapy with tyrosine kinase inhibitors (TKIs) for epidermal growth factor receptor (EGFR) positive patients in adenocarcinoma or mixed adenosquamus...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Gaga, Mina, Huang, Haidong, Darwiche, Kaid, Rapti, Aggeliki, Hohenforst-Schmidt, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243233/
https://www.ncbi.nlm.nih.gov/pubmed/28101783
http://dx.doi.org/10.1186/s40169-017-0135-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243233/
https://www.ncbi.nlm.nih.gov/pubmed/28101783
http://dx.doi.org/10.1186/s40169-017-0135-8

Ejemplares similares